AU543916B2 - Spiro(imidazolidine-indolines) and spiro (imidazolidine- azaindolines) - Google Patents
Spiro(imidazolidine-indolines) and spiro (imidazolidine- azaindolines)Info
- Publication number
- AU543916B2 AU543916B2 AU28563/84A AU2856384A AU543916B2 AU 543916 B2 AU543916 B2 AU 543916B2 AU 28563/84 A AU28563/84 A AU 28563/84A AU 2856384 A AU2856384 A AU 2856384A AU 543916 B2 AU543916 B2 AU 543916B2
- Authority
- AU
- Australia
- Prior art keywords
- spiro
- imidazolidine
- trione
- indoline
- pyridylmethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- -1 imidazolidine- azaindolines Chemical class 0.000 title abstract 3
- 125000003003 spiro group Chemical group 0.000 title 2
- CFTDUPXEWGBTHG-UHFFFAOYSA-N 2,3-dihydro-1H-indole imidazolidine Chemical class N1CCC2=CC=CC=C12.N1CNCC1 CFTDUPXEWGBTHG-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- JIEZEWWXWYGFRD-UHFFFAOYSA-N 2,3-dihydro-1h-pyrrolo[2,3-c]pyridine Chemical compound C1=NC=C2NCCC2=C1 JIEZEWWXWYGFRD-UHFFFAOYSA-N 0.000 abstract 1
- 208000002249 Diabetes Complications Diseases 0.000 abstract 1
- 206010012655 Diabetic complications Diseases 0.000 abstract 1
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 abstract 1
- 150000001323 aldoses Chemical class 0.000 abstract 1
- 230000001684 chronic effect Effects 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000007858 starting material Substances 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Neurosurgery (AREA)
- Ophthalmology & Optometry (AREA)
- Biomedical Technology (AREA)
- Emergency Medicine (AREA)
- Neurology (AREA)
- Endocrinology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Cosmetics (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- External Artificial Organs (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Fats And Perfumes (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/497,962 US4464380A (en) | 1983-05-25 | 1983-05-25 | Imidazolidinedione derivatives |
| US497962 | 1983-05-25 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2856384A AU2856384A (en) | 1984-11-29 |
| AU543916B2 true AU543916B2 (en) | 1985-05-09 |
Family
ID=23979057
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU28563/84A Ceased AU543916B2 (en) | 1983-05-25 | 1984-05-24 | Spiro(imidazolidine-indolines) and spiro (imidazolidine- azaindolines) |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US4464380A (enEXAMPLES) |
| EP (1) | EP0127412B1 (enEXAMPLES) |
| JP (1) | JPS604183A (enEXAMPLES) |
| KR (1) | KR860001869B1 (enEXAMPLES) |
| AT (1) | ATE57531T1 (enEXAMPLES) |
| AU (1) | AU543916B2 (enEXAMPLES) |
| CA (1) | CA1266270A (enEXAMPLES) |
| DE (1) | DE3483402D1 (enEXAMPLES) |
| DK (1) | DK163924C (enEXAMPLES) |
| ES (2) | ES532736A0 (enEXAMPLES) |
| FI (1) | FI78699C (enEXAMPLES) |
| GR (1) | GR82020B (enEXAMPLES) |
| HU (1) | HU190548B (enEXAMPLES) |
| IE (1) | IE57520B1 (enEXAMPLES) |
| IL (1) | IL71904A (enEXAMPLES) |
| PH (1) | PH21151A (enEXAMPLES) |
| PL (3) | PL143070B1 (enEXAMPLES) |
| PT (1) | PT78625A (enEXAMPLES) |
| YU (2) | YU43931B (enEXAMPLES) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE37371T1 (de) * | 1984-08-20 | 1988-10-15 | Pfizer | Verfahren zur herstellung asymmetrischer hydantoine. |
| US4762839A (en) * | 1985-06-06 | 1988-08-09 | Tanabe Seiyaku Co., Ltd. | Quinazolinone copmpounds useful for the prophyloxis and treatment of diabetic complications |
| JPS63132889A (ja) * | 1986-11-21 | 1988-06-04 | Tanabe Seiyaku Co Ltd | キナゾリノン誘導体 |
| US4841079A (en) * | 1987-08-07 | 1989-06-20 | Pfizer, Inc. | Process for the production of asymmetric hydantoins |
| DK0769497T3 (da) * | 1995-10-18 | 2003-04-07 | Hoffmann La Roche | Hydroxymethylering af tocopheroler |
| WO2000037470A1 (en) | 1998-12-19 | 2000-06-29 | Janssen Pharmaceutica N.V. | Antihistaminic spiro compounds |
| JP2009526044A (ja) * | 2006-02-07 | 2009-07-16 | アストラゼネカ・アクチエボラーグ | 新規な化合物ｉ |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3821383A (en) * | 1972-07-10 | 1974-06-28 | Ayerst Mckenna & Harrison | Compositions for and a method of treating diabetic complications |
| US4200642A (en) * | 1978-08-21 | 1980-04-29 | Pfizer Inc. | Spiro-oxazolidindiones |
| ZA806623B (en) * | 1979-11-13 | 1981-12-30 | Ici Ltd | Substituted indoline-2-one derivatives |
| AU532110B2 (en) * | 1979-11-13 | 1983-09-15 | Ici Ltd. | Spiro(imidazolidine-4,3:-indoline)-2,2:5-trione derivatives |
| US4248882A (en) * | 1980-02-12 | 1981-02-03 | Pfizer Inc. | Treating diabetes-associated complications with hydantoin amines |
| IE52879B1 (en) * | 1981-05-12 | 1988-03-30 | Ici Plc | Pharmaceutical spiro-hydantoin derivatives |
-
1983
- 1983-05-25 US US06/497,962 patent/US4464380A/en not_active Expired - Fee Related
-
1984
- 1984-05-21 DE DE8484303420T patent/DE3483402D1/de not_active Expired - Lifetime
- 1984-05-21 EP EP84303420A patent/EP0127412B1/en not_active Expired - Lifetime
- 1984-05-21 AT AT84303420T patent/ATE57531T1/de not_active IP Right Cessation
- 1984-05-21 PT PT78625A patent/PT78625A/pt not_active IP Right Cessation
- 1984-05-22 DK DK250084A patent/DK163924C/da not_active IP Right Cessation
- 1984-05-23 CA CA000454883A patent/CA1266270A/en not_active Expired - Lifetime
- 1984-05-23 PH PH30711A patent/PH21151A/en unknown
- 1984-05-23 IL IL71904A patent/IL71904A/xx unknown
- 1984-05-23 YU YU897/84A patent/YU43931B/xx unknown
- 1984-05-23 PL PL1984242850A patent/PL143070B1/pl unknown
- 1984-05-23 PL PL1984247804A patent/PL143290B1/pl unknown
- 1984-05-23 ES ES532736A patent/ES532736A0/es active Granted
- 1984-05-23 PL PL25285084A patent/PL252850A1/xx unknown
- 1984-05-24 KR KR1019840002843A patent/KR860001869B1/ko not_active Expired
- 1984-05-24 GR GR74816A patent/GR82020B/el unknown
- 1984-05-24 AU AU28563/84A patent/AU543916B2/en not_active Ceased
- 1984-05-24 FI FI842079A patent/FI78699C/fi not_active IP Right Cessation
- 1984-05-24 IE IE1294/84A patent/IE57520B1/en not_active IP Right Cessation
- 1984-05-24 HU HU842021A patent/HU190548B/hu not_active IP Right Cessation
- 1984-05-25 JP JP59106330A patent/JPS604183A/ja active Granted
-
1985
- 1985-03-01 ES ES540858A patent/ES8607304A1/es not_active Expired
-
1986
- 1986-12-11 YU YU2122/86A patent/YU43958B/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IE851918L (en) | An indole derivative. | |
| MY102038A (en) | 4-substituted androstendione derivatives and process for their preparation | |
| IE852841L (en) | Tetrazole-substituted indole derivatives | |
| AU7535087A (en) | The process for the manufacture of spiro-linked pyrrolidine-2,5-dione derivatives | |
| AU543916B2 (en) | Spiro(imidazolidine-indolines) and spiro (imidazolidine- azaindolines) | |
| AU7767287A (en) | New imidazolylguanidine derivatives, processes for their preparation and medicaments containing these compounds | |
| IE851155L (en) | Benzo-(pyrano and thiopyrano)-pyridines | |
| AU529996B2 (en) | Synthesis of vincaminic acid derivatives | |
| MY103765A (en) | Azolidinedione derivatives | |
| IE800109L (en) | Spiro-quinolylhydantoins | |
| IE800672L (en) | Spiro-quinolone hydantoins | |
| AU2773184A (en) | Spiro(imidazolidine-4,3:-indoline) derivatives | |
| AU7575187A (en) | New tetracyclic indole derivatives | |
| HUT44769A (en) | Process for producing spiro/benzofuran-2(3h),1'-cycloheptane/ derivatives and pharmaceutical preparations comprising these compounds | |
| AU566869B2 (en) | Spiro (imidazolidine-4,3'-indoline) 2,2',5-triones | |
| FI832959A0 (fi) | Spiro/2h-1,4-benzodiazepin-3(5h)4'-piperidin och 3'-pyrrolidin/foereningar, foerfarande foer deras framstaellning och deras anvaendning som laekemedel |